Ayako Suzuki, Anna Mae Diehl
文献索引:10.1146/annurev-med-051215-031109
全文:HTML全文
Nonalcoholic steatohepatitis (NASH) has become a major cause of cirrhosis and liver-related deaths worldwide. NASH is strongly associated with obesity and the metabolic syndrome, conditions that cause lipid accumulation in hepatocytes (hepatic steatosis). It is not well understood why some, but not other, individuals with hepatic steatosis develop NASH. The factors that determine whether or not NASH progresses to cirrhosis are also unclear. This review summarizes key components of NASH pathogenesis and discusses how inherent and acquired variations in regulation of these processes impact the risk for NASH and NASH cirrhosis.
Gene Editing: A New Tool for Viral Disease
2017-01-18 [10.1146/annurev-med-051215-031129] |
The Type I Interferonopathies
2017-01-18 [10.1146/annurev-med-050715-104506] |
Esophageal Adenocarcinoma: Screening, Surveillance, and Mana...
2017-01-18 [10.1146/annurev-med-050715-104218] |
Management of Rectal Cancer Without Radical Resection
2017-01-18 [10.1146/annurev-med-062915-021419] |
The End of Nihilism: Systemic Therapy of Advanced Non–Small ...
2017-01-18 [10.1146/annurev-med-042915-102442] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved